854 results on '"ABE, Riichiro"'
Search Results
2. Biomarkers and patient-related factors associated with clinical outcomes in dupilumab-treated atopic dermatitis
3. Improvement of the Ocular Prognosis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A National Survey in Japan
4. Drug-Induced Hypersensitivity Syndrome/Drug Reaction With Eosinophilia and Systemic Symptoms: Predictive Score and Outcomes
5. Development and Validation of a Novel Score to Predict Mortality in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: CRISTEN
6. New insights into the diagnosis and management of Stevens–Johnson syndrome and toxic epidermal necrolysis
7. Improvement of the Ocular Prognosis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A National Survey in Japan
8. Association of HLA-A∗11:01, HLA-B∗39:01, and HLA-B∗56:03 with salazosulfapyridine-induced cutaneous adverse drug reactions
9. Risk factors for sepsis and effects of pretreatment with systemic steroid therapy for underlying condition in SJS/TEN patients: Results of a nationwide cross-sectional survey in 489 Japanese patients
10. Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis
11. Phase I/II clinical trial of brentuximab vedotin for pretreated Japanese patients with CD30‐positive cutaneous T‐cell lymphoma.
12. Can dermatologists reach their full potential in teledermatology? A validation study of diagnostic performance of skin diseases in live video conferencing teledermatology.
13. Resminostat for Maintenance Treatment in Patients with Advanced Stage Mycosis Fungoides or Sézary Syndrome: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase 2 Trial
14. Bexarotene-induced hypothyroidism and dyslipidemia; a nation-wide study
15. Deep Neural Network for Early Image Diagnosis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
16. Multiple papules on the face in a kidney transplant recipient
17. The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016-2018
18. Inhibition of Endoglin Exerts Antitumor Effects through the Regulation of Non-Smad TGF-β Signaling in Angiosarcoma
19. Risk factors for lymph node metastasis in cutaneous squamous cell carcinoma: a long-term retrospective study of Japanese patients
20. Histopathology of Severe Drug Eruptions
21. Congenital leukonychia caused by a mutation in GJB2
22. Loss of dynamin-related protein 1 (Drp1) does not affect epidermal development or UVB-induced apoptosis but does accelerate UVB-induced carcinogenesis
23. SJS/TEN 2019: From science to translation
24. Exploring patient background and biomarkers associated with the development of dupilumab-associated conjunctivitis and blepharitis
25. Single-cell spatial proteomics identifies the JAK/STAT pathway as an actionable therapeutic target in lethal cutaneous drug reactions
26. Dystonin modifiers of junctional epidermolysis bullosa and models of epidermolysis bullosa simplex without dystonia musculorum
27. Updates in SJS/TEN: collaboration, innovation, and community
28. Deep dermatophytosis caused by Trichophyton rubrum in an elderly patient with CARD9 deficiency: A case report and literature review
29. Two cases of infancy associated eosinophilic pustular folliculitis (I‐EPF) comparing the profile of infiltrating cells with classic EPF by immunohistochemical study
30. The significance of tumor cells-derived MFG-E8 in tumor growth of angiosarcoma
31. Cultured Epidermal Autografts from Clinically Revertant Skin as a Potential Wound Treatment for Recessive Dystrophic Epidermolysis Bullosa
32. Efficient Gene Reframing Therapy for Recessive Dystrophic Epidermolysis Bullosa with CRISPR/Cas9
33. Culprit Drugs Induce Specific IL-36 Overexpression in Acute Generalized Exanthematous Pustulosis
34. Hypoxia accelerates the progression of angiosarcoma through the regulation of angiosarcoma cells and tumor microenvironment
35. Deep dermatophytosis caused by Trichophyton rubrum in an elderly patient with CARD9 deficiency: A case report and literature review.
36. Two cases of infancy associated eosinophilic pustular folliculitis (I‐EPF) comparing the profile of infiltrating cells with classic EPF by immunohistochemical study.
37. Possible relation of cathepsin C activity and seasonal fluctuation of skin lesions in Papillon-Lefèvre syndrome
38. The ability of biomarkers to assess the severity of atopic dermatitis
39. RESMAIN: results of a multicenter, randomized, double blind, placebocontrolled trial to evaluate resminostat for maintenance treatment in advanced stage mycosis fungoides or Sézary syndrome
40. Atypical epidermolytic palmoplantar keratoderma is a minimal phenotypic variant of epidermolytic ichthyosis: A new insight from ultrastructural findings
41. Exploring patient background and biomarkers associated with the development of dupilumab-associated conjunctivitis and blepharitis
42. Differential Effects of HLA-B∗15:11 and HLA-A∗31:01 on Carbamazepine-Induced Cutaneous Adverse Reactions
43. Atypical localization of congenital triangular alopecia associated with Down's syndrome
44. The development of induced pluripotent stem cell-derived mesenchymal stem/stromal cells from normal human and RDEB epidermal keratinocytes
45. Bone marrow transplantation restores epidermal basement membrane protein expression and rescues epidermolysis bullosa model mice
46. Establishment of integration-free induced pluripotent stem cells from human recessive dystrophic epidermolysis bullosa keratinocytes
47. SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation
48. Drp1 regulates mitochondrial morphology and cell proliferation in cutaneous squamous cell carcinoma
49. The ability of biomarkers to assess the severity of atopic dermatitis
50. ISID1436 - Lesional skin histology in drug-induced hypersensitivity syndrome: A single center 10-year experience of 37 patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.